UCB eyes Middle East and Africa growth, sells India facility – PharmaTimes

by admin on November 26, 2012

UCB eyes Middle East and Africa growth, sells India facility
PharmaTimes
from the former's previous partner in the region, the Rx Group, to market Cimzia (certolizumab pegol) for rheumatoid arthritis and Crohn's disease, Vimpat (lacosamide) for epilepsy and Neupro (rotigotine) for Parkinson's disease and restless legs

and more »

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: